ILD_ENDPOINTS
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Filter registries None
0
Check pre-conditions, main-only, mode, ICD version None
0
Check minimum number of events None
0
Extra metadata
List of similar endpoints to
Interstitial lung disease endpoints
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3091 | 1245 | 1846 |
| Unadjusted prevalence (%) | 1.00 | 0.72 | 1.37 |
| Mean age at first event (years) | 65.24 | 62.70 | 66.95 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.07 | 5.70 [3.30, 9.85] | 4.4e-10 | 758 |
| 15 years | 0.01 | 1.95 [1.30, 2.92] | 1.2e-3 | 203 |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: ILD_ENDPOINTS – Interstitial lung disease endpoints
GWS hits: 27
before Interstitial lung disease endpoints
after Interstitial lung disease endpoints
Loading survival analyses plot
Loading survival analyses table
